Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Photronics, Inc. (PLAB) Appoints David Garcia to its Board
-
Lexaria Bioscience (LEXX) Forms New Scientific Advisory Board
-
MSCI (MSCI) Appoints June Yang to its Board
-
CenterPoint Energy (CNP) Appoints Dean Seavers to its Board
-
Merck's (MRK) KEYTRUDA Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment
-
Brainsway (BWAY) Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
-
Paragon 28 (FNA) Appoints Dave Demski to its Board
-
New Oriental Education (EDU) Announces Changes in Board and Committee Composition
-
Serve Robotics (SERV) Announces Appointment of Lily Sarafan to its Board of Directors
-
Corvus Pharma (CRVS) Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib
-
ADP Employment Change (Nov) 146K vs 150K Expected
-
Edwards Lifesciences (EW) Outlines Growth Strategy
-
Udemy (UDMY) Appoints Marylou Maco and Debra Chrapaty to its Board
-
Eos Energy Enterprises (EOSE) Appoints Francis Richey as CTO
-
Clearside Biomedical (CLSD) Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
-
Stanford Study Reveals AI-Enhanced Smartphone Facial Scans as a Novel Approach to Identifying Anatomical Contributors to Sleep Disorders
-
GE HealthCare (GEHC) Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
-
Codexis (CDXS) Appoints Raymond De Vre to its Board
-
AlloVir (ALVR) and Kalaris Therapeutics to Merge
-
NVIDIA (NVDA) Appoints Ellen Ochoa to its Board
-
Stanford Markets Launches New Tools to Boost Financial Transparency with Data-Driven Solutions
-
QXO, Inc. (QXO) Appoints Ashwin Rao as Chief AI Officer
-
CalciMedica (CALC) Appoints Stephen Bardin as CFO
-
Phunware (PHUN) Appoints Rahul Mewawalla as Board Chairman
-
Antero Midstream Corporation (AM) Reports Q3, Announces Board Changes
-
ADP Employment Change (Oct) 233K vs 111K Expected
-
Super League Enterprise (SLE) Completes Initial Stage of Equity Exchange Transfer with Infinite Reality
-
Kraft Heinz (KHC) Appoints Debby Soo to its Board
-
Disc Medicine (IRON) Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer
-
LPL Financial (LPLA) Announces Rich Steinmeier Named Chief Executive Officer
-
Regeneron (REGN) Reports Three-year Results for EYLEA HD Injection 8 mg
-
Nektar Therapeutics (NKTR) Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy
-
HeartBeam, Inc (BEAT) Appoints Robert Eno as CEO
-
Levi (LEVI) Appoints Dan Geballe to its Board
-
F5 Networks (FFIV) Appoints Maya McReynolds and Julie Gonzalez to its Board
-
Twist Bioscience Corporation (TWST) Appoints Mike Fero as Chief Information Officer
-
Microsoft (MSFT) Unveils Microsoft Cloud for Healthcare innovations
-
CareDx (CDNA) Appoints Jing Huang Chief Data and AI Officer
-
Eupraxia Pharmaceuticals (EPRX) Strengthens Senior Management Team
-
ADP Employment Change (Sep) 143K vs 125K Expected
-
Vera Therapeutics (VERA) Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
-
Vera Therapeutics Inc. (VERA) Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results
-
LPL Financial (LPLA) Announces Termination of President and CEO Dan H. Arnold
-
Korn Ferry (KFY) Appoints Russ Hagey to its Board
-
Stanford Digital Economy Lab Introduces The Digitalist Papers: A Visionary Exploration of Democracy in the Age of AI
-
Tanger (SKT) Announces the Election of Retail Industry Leader Sonia Syngal to its Board of Directors
-
Cidara Therapeutics (CDTX) Announces Scientific Advisory Board with Infectious Disease Experts
-
TG Therapeutics (TGTX): New BRIUMVI Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
-
TG Therapeutics (TGTX) Reports New BRIUMVI Data Showing 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment
-
Edgewell Personal Care Company (EPC) Appoints Stephanie Stahl to its Board

